Status
Conditions
Treatments
About
This is a multicentric, randomised, double-blind, placebo-controlled study that will consist of two consecutive phases:
Follow-up visits will be scheduled at 1, 4 and 12 weeks after randomization. The main aim of the study is to assess the efficacy of FMT in ameliorating diarrhea experienced by patients with idiopathic pulmonary fibrosis treated with nintedanib.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Phase 1 (faecal samples collection)
Phase 2 (FMT procedure)
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
114 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal